Trazodone Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00656 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 46 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obsessive-compulsive disorder | KG + DL |
| 2 | schizotypal personality disorder | KG + DL |
| 3 | histrionic personality disorder (disease) | KG + DL |
| 4 | paranoid personality disorder | KG + DL |
| 5 | schizoid personality disorder | KG + DL |
| 6 | benign paroxysmal torticollis of infancy | KG + DL |
| 7 | agoraphobia | KG + DL |
| 8 | dysthymic disorder | KG + DL |
| 9 | phobic disorder | KG + DL |
| 10 | Ohdo syndrome and variants | KG + DL |
| 11 | melancholia | KG + DL |
| 12 | neurotic depression | KG + DL |
| 13 | blepharophimosis - intellectual disability syndrome, Ohdo type | KG + DL |
| 14 | childhood apraxia of speech | KG + DL |
| 15 | dependent personality disorder | KG + DL |
| 16 | mixed anxiety and depressive disorder | KG + DL |
| 17 | Keppen-Lubinsky syndrome | KG + DL |
| 18 | narcissistic personality disorder | KG + DL |
| 19 | surfactant metabolism dysfunction, pulmonary | KG + DL |
| 20 | schizophrenia | KG + DL |
| 21 | ligneous conjunctivitis | KG + DL |
| 22 | neurotic disorder | KG + DL |
| 23 | congenital isolated adrenocorticotropic hormone deficiency (disease) | KG + DL |
| 24 | attention deficit-hyperactivity disorder | KG + DL |
| 25 | avoidant personality disorder | KG + DL |
| 26 | major affective disorder | KG + DL |
| 27 | chromosome 15q26-qter deletion syndrome | KG + DL |
| 28 | autosomal dominant slowed nerve conduction velocity | KG + DL |
| 29 | retinal dystrophy with or without extraocular anomalies | KG + DL |
| 30 | post-traumatic stress disorder | KG + DL |
| 31 | faciodigitogenital syndrome | KG + DL |
| 32 | bipolar disorder | KG + DL |
| 33 | vitamin B12-responsive methylmalonic acidemia | KG + DL |
| 34 | congenital disorder of glycosylation with defective fucosylation | KG + DL |
| 35 | syndromic myopia | KG + DL |
| 36 | hydranencephaly (disease) | KG + DL |
| 37 | myopia X-linked | KG + DL |
| 38 | Charcot-Marie-Tooth disease, demyelinating, type 1G | KG + DL |
| 39 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 40 | chondromyxoid fibroma | KG + DL |
| 41 | myopia 26, X-linked, female-limited | KG + DL |
| 42 | distal 17p13.3 microdeletion syndrome | KG + DL |
| 43 | atypical glycine encephalopathy | KG + DL |
| 44 | manic bipolar affective disorder | KG + DL |
| 45 | attention deficit hyperactivity disorder, inattentive type | KG + DL |
| 46 | hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.